TrialJournal of clinical hypertension (Greenwich, Conn.)2018

Efficacy and safety of sacubitril/valsartan in patients with essential hypertension uncontrolled by olmesartan: A randomized, double-blind, 8-week study.

Deanna G Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.